CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

The London Clinic

Emma Spellman, Chief Operating Officer

Coping With Ongoing Developments In Oncology

Emma Spellman

Emma Spellman

How do you foresee ongoing changes in services for oncology shaping the landscape of challenges you face in satisfying your business requirements?


The ongoing changes and innovations in oncology are a challenge to any organisation. The London Clinic is continually adapting its approach to ensure we deliver exceptional patient care with options to meet their individual needs. This requires ongoing investment and agile working. We at the London Clinic are evolving our strategies to ensure we meet future oncology challenges. Our focus includes:


Technological Advancements: As new technologies emerge, such as precision medicine, gene therapy and immunotherapy, we will adapt our services to be at the forefront of the trial and align our key areas of clinical strategy to these advancements


Patient-Centric Care: We have always been focused on delivering patient-centric care. We prioritise the development of products or services that cater to the individual needs and preferences of cancer patients, and this could be provided by the London Clinic or in partnership.


Partnerships: The interdisciplinary nature of oncology care requires a comprehensive service offering, and we foresee forging partnerships with other healthcare providers or organisations to deliver comprehensive solutions that provide personalised patient care.


Cost Pressures: Rising healthcare costs and reimbursement challenges will impact the viability of delivering oncology care; we continue to evolve our care and ensure that we offer value-based care


Compliance: Changes in regulations surrounding oncology treatments will need us to be flexible and agile to ensure compliance and adherence to standards.


Data Management: With the increasing emphasis on data-driven decision-making in healthcare, we, like other organisations, face challenges related to the collection, storage, and analysis of large volumes of patient data.


Are there specific challenges within oncology that you believe are not adequately met by the current range of services?


The London Clinic has a wide range of services, and we are fortunate to be able to provide a comprehensive service offering to our patients.Addressing these challenges requires a multifaceted approach that, for us, will involve collaboration with healthcare providers, investment 


Our current service does have some general challenges that are commonly faced by other organisations and include:


Innovative Treatments: The field of oncology is rapidly evolving, with new treatments and technologies constantly being developed. Ensuring that patients have access to the latest advancements in cancer care, such as targeted therapies, immunotherapy, and precision medicine, is a challenge


Holistic Care and Patient Experience: Cancer diagnosis and treatment can be emotionally and physically taxing for patients. Providing comprehensive support services, such as psychological counselling, palliative care, and survivorship programs, is important for addressing the holistic needs of patients and their families.


Addressing these challenges requires a multifaceted approach that, for us, will involve collaboration with healthcare providers, investment in resources and infrastructure, and a focus on patient-centred care. The London Clinic, like many healthcare institutions, continuously evaluates its services to identify areas for improvement and innovation in oncology care.


Continuously invest in your own professional development through ongoing education, training, and certifications relevant to oncology leadership. This will help you stay competitive and effective in your role


What advice or recommendations would you offer to professionals in roles similar to yours, particularly those working in other hospitals within the field of oncology?


As an associate director in oncology, I would like to think that any professional involved in the delivery of Oncology services is compassionate and driven to provide patients and their families exceptional care. It is important that we


Stay Updated: Oncology is a rapidly evolving landscape; I believe it’s essential to stay informed about the latest advancements in treatments, technologies, and research. This includes attending conferences, reading scientific literature, and networking with colleagues in the field.


Develop Leadership Skills: As a leader in oncology, it’s important to hone your leadership skills to effectively guide and motivate your team. This includes communication, decision-making, conflict resolution, and strategic planning skills.


Focus on Patient-Centred Care: Keep the patient at the centre of everything you do. Advocate for approaches that prioritise patient outcomes, experiences, and quality of life throughout their cancer journey.


Promote Collaboration: Foster collaboration and teamwork among multidisciplinary healthcare providers involved in oncology care, including physicians, nurses, researchers, pharmacists, and allied health professionals. Encourage a culture of mutual respect, communication, and knowledge sharing.


Embrace and Promote Innovation: Be open to adopting innovative approaches to oncology care, such as precision medicine, immunotherapy, and digital health solutions. Explore opportunities for clinical trials, research partnerships, and technology integration to improve patient outcomes.


Advocate for Equity and Access: Advocate for equitable access to oncology care for all patients, regardless of their background, socioeconomic status, or geographic location. Work towards reducing disparities in cancer outcomes and improving healthcare access and affordability.


Invest in Professional Development: Continuously invest in your own professional development through ongoing education, training, and certifications relevant to oncology leadership. This will help you stay competitive and effective in your role.


I think these are essential to effectively navigate the complexities of oncology leadership and contribute to improving outcomes for cancer patients.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/cxoinsight/coping-with-ongoing-developments-in-oncology-nwid-2359.html